Traws Pharma, Inc. — Director's Dealing 2025

Dec 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2025-12-12

Reporting Person: Clarke Trafford (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-12	Common Stock	A	6157	—	Acquired	6157	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-12	Stock Option (right to purchase)	$2.33	A	24629	Acquired	2035-12-12	Common Stock (24629)	Direct

Footnotes

F1: Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.

F2: The options vest 100% on the first anniversary of the grant date.